These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 30892933)
1. Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization. Guise E; Engel JE; Williams ML; Mahdi F; Bidwell GL; Chade AR Am J Physiol Renal Physiol; 2019 May; 316(5):F1016-F1025. PubMed ID: 30892933 [TBL] [Abstract][Full Text] [Related]
2. Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease. Chade AR; Williams ML; Guise E; Vincent LJ; Harvey TW; Kuna M; Mahdi F; Bidwell GL Kidney Int; 2018 Apr; 93(4):842-854. PubMed ID: 29273331 [TBL] [Abstract][Full Text] [Related]
3. Recovery of Renal Function following Kidney-Specific VEGF Therapy in Experimental Renovascular Disease. Engel JE; Williams ML; Williams E; Azar C; Taylor EB; Bidwell GL; Chade AR Am J Nephrol; 2020; 51(11):891-902. PubMed ID: 33130676 [TBL] [Abstract][Full Text] [Related]
5. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure. Favreau F; Zhu XY; Krier JD; Lin J; Warner L; Textor SC; Lerman LO Kidney Int; 2010 Dec; 78(11):1110-8. PubMed ID: 20463652 [TBL] [Abstract][Full Text] [Related]
6. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach. Chade AR; Kelsen S Am J Physiol Renal Physiol; 2012 May; 302(10):F1342-50. PubMed ID: 22357917 [TBL] [Abstract][Full Text] [Related]
7. Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage Polarization. Engel JE; Williams E; Williams ML; Bidwell GL; Chade AR Hypertension; 2019 Nov; 74(5):1113-1123. PubMed ID: 31542966 [TBL] [Abstract][Full Text] [Related]
8. Role of renal microcirculation in experimental renovascular disease. Iliescu R; Fernandez SR; Kelsen S; Maric C; Chade AR Nephrol Dial Transplant; 2010 Apr; 25(4):1079-87. PubMed ID: 19934087 [TBL] [Abstract][Full Text] [Related]
9. Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease. Chade AR; Tullos N; Stewart NJ; Surles B J Am Soc Nephrol; 2015 May; 26(5):1071-80. PubMed ID: 25377076 [TBL] [Abstract][Full Text] [Related]
10. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Chade AR; Kelsen S Circ Cardiovasc Interv; 2010 Aug; 3(4):376-83. PubMed ID: 20587789 [TBL] [Abstract][Full Text] [Related]
11. Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis. Eirin A; Ebrahimi B; Zhang X; Zhu XY; Tang H; Crane JA; Lerman A; Textor SC; Lerman LO Circ Cardiovasc Interv; 2012 Oct; 5(5):720-8. PubMed ID: 23048054 [TBL] [Abstract][Full Text] [Related]
12. Early superoxide scavenging accelerates renal microvascular rarefaction and damage in the stenotic kidney. Kelsen S; He X; Chade AR Am J Physiol Renal Physiol; 2012 Aug; 303(4):F576-83. PubMed ID: 22622460 [TBL] [Abstract][Full Text] [Related]
14. The Metabolic Syndrome Does Not Affect Development of Collateral Circulation in the Poststenotic Swine Kidney. Zhang X; Kim SR; Ferguson CM; Ebrahimi B; Hedayat AF; Lerman A; Lerman LO Am J Hypertens; 2018 Nov; 31(12):1307-1316. PubMed ID: 30107490 [TBL] [Abstract][Full Text] [Related]
15. Renoprotective effects of hepatocyte growth factor in the stenotic kidney. Stewart N; Chade AR Am J Physiol Renal Physiol; 2013 Mar; 304(6):F625-33. PubMed ID: 23269649 [TBL] [Abstract][Full Text] [Related]
16. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Eirin A; Zhu XY; Krier JD; Tang H; Jordan KL; Grande JP; Lerman A; Textor SC; Lerman LO Stem Cells; 2012 May; 30(5):1030-41. PubMed ID: 22290832 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. Kelsen S; Hall JE; Chade AR Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482 [TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease. Tullos NA; Stewart NJ; Davidovich R; Chade AR Nephrol Dial Transplant; 2015 Apr; 30(4):584-93. PubMed ID: 25438341 [TBL] [Abstract][Full Text] [Related]